UVA researchers develop online tool to combat childhood diarrheal diseases

University of Virginia researchers are developing a flexible online tool for navigating information used in the fight to save children from deadly diarrheal diseases by identifying transmission hotspots and accelerating the deployment of treatments and new vaccines.

Sartorius Stedim Biotech publishes unaudited results for the first nine months of 2024 – Biotech Investments

Sartorius Stedim Biotech SA / Key word(s): 9 Month figures Sartorius Stedim Biotech publishes unaudited results for the first nine months of 2024 17-Oct-2024 /

October 18, 2024

Risk adjusted net present value: What is the current valuation of AstraZeneca’s AZD-9574?

AZD-9574 is a small molecule commercialized by AstraZeneca, with a leading Phase II program in Vaginal Cancer.

April 17, 2024

Stryker’s Lisa Kloes talks cementless implants, robotics as future of knee business

Listen to the article 5 min This audio is auto-generated. Please let us know if you have feedback. Stryker’s knee segment, which made up 11%

November 1, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.